Literature DB >> 8417871

Prolonged intracorporeal support of gas exchange with an intravenacaval oxygenator.

S A Conrad1, J M Eggerstedt, V F Morris, M D Romero.   

Abstract

Patients with severe respiratory failure undergoing conventional mechanical ventilation typically are exposed to levels of ventilator support that place the patient at risk of barotrauma or oxygen toxicity. In severe cases, gas exchange may be inadequate despite maximal ventilator support. We report two cases of advanced respiratory failure in which augmentation of gas exchange was provided for prolonged periods (18 and 13 days) with an intravenacaval hollow-fiber membrane oxygenator (IVOX). Following implantation, significant reductions in ventilator support were possible with improvement in arterial blood gas values. No significant complications were noted. IVOX can provide clinically useful augmentation of gas exchange in respiratory failure and can be used for prolonged periods.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417871     DOI: 10.1378/chest.103.1.158

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population.

Authors:  P Lange; J Parner; E Prescott; C S Ulrik; J Vestbo
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

2.  ARDS and sepsis--definitions and new therapy.

Authors:  J S McLean; R J Byrick
Journal:  Can J Anaesth       Date:  1993-07       Impact factor: 5.063

3.  Supporting the injured lung.

Authors:  K M Sim; T W Evans
Journal:  BMJ       Date:  1993-11-20

4.  Effect of impeller design and spacing on gas exchange in a percutaneous respiratory assist catheter.

Authors:  R Garrett Jeffries; Brian J Frankowski; Greg W Burgreen; William J Federspiel
Journal:  Artif Organs       Date:  2014-04-22       Impact factor: 3.094

5.  Reduction of ventilator settings allowed by intravenous oxygenator (IVOX) in ARDS patients.

Authors:  J P Mira; F Brunet; M Belghith; O Soubrane; J L Termignon; B Renaud; I Hamy; M Monchi; E Deslande; L Fierobe
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.